Nov 25 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- HY LOSS AFTER TAX ATTRIBUTABLE NZ$5.1 MILLION VERSUS LOSS NZ$13.5 MILLION
- HY REVENUE FROM ORDINARY ACTIVITIES – PRODUCT SALES UP 96% TO NZ$17.7 MILLION
- UPGRADED FY22 PRODUCT REVENUE GUIDANCE (ON CONSTANT CURRENCY BASIS) TO NZ$34-37 MILLION
- EXPECTS PRODUCT GROSS MARGINS TO CONTINUE TO IMPROVE, TO BE BETWEEN 73-75% FOR FY22
- CONSTRUCTION OF AROA'S SECOND MANUFACTURING FACILITY EXPECTED TO COMPLETE IN CY21
Nov 25 (Reuters) - Aroa Biosurgery Ltd (ARX) : HY LOSS AFTER...
Add to My Watchlist
What is My Watchlist?